Beam Therapeutics, Inc. (BEAM)
27.94
-1.59
(-5.38%)
USD |
NASDAQ |
May 15, 16:00
27.90
-0.04
(-0.14%)
After-Hours: 17:24
Beam Therapeutics Profit Margin (Quarterly) : -297.2% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -639.5% |
| Twist Bioscience Corp. | -39.76% |
| Recursion Pharmaceuticals, Inc. | -1.82K% |
| Anika Therapeutics, Inc. | -17.07% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.87% |
| Return on Assets | -4.56% |
| Return on Invested Capital | -5.07% |
| Gross Profit Margin (Quarterly) | 82.34% |
| Operating Margin (Quarterly) | -337.8% |
| Return on Net Operating Assets | -31.57% |